Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| University of Washington, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| University of Washington, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| University of Washington, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| University of Washington, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 9 | 1 |
| University of Washington, Medical Devices Deals, 2010 to YTD 2016 | 10 | 1 |
| University of Washington, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 11 | 3 |
| University of Washington, Pharmaceuticals &Healthcare, Deal Details | 14 | 24 |
| Venture Financing | 14 | 1 |
| Nexgenia Raises USD0.5 Million in Seed Financing Round | 14 | 1 |
| Partnerships | 15 | 1 |
| C2N Diagnostics Expands Licensing Agreement with Washington University School of Medicine | 15 | 1 |
| Juno Therapeutics and Fred Hutchinson Cancer Research Center Enter into Joint Venture | 16 | 1 |
| Novo Nordisk Enters into Research Agreement with UW Medicine | 17 | 1 |
| Johnson &Johnson Innovation Enters into Research Agreement with Washington University | 18 | 1 |
| GenVec Enters into Agreement with Washington University at St. Louis | 19 | 1 |
| Kineta, KPI Therapeutics Enter into Partnership with UW Medicine and University of Washington | 20 | 1 |
| OncoSec Medical Enters into Research Agreement with University of Washington | 21 | 1 |
| Cumberland Emerging Technologies Enters Into Agreement With Washington University in St. Louis | 22 | 1 |
| Horizon Discovery Enters Into Co-Development Agreement With University Of Washington | 23 | 1 |
| Fred Hutchinson Cancer Research Enters Into An Agreement With University of Washington | 24 | 1 |
| Pfizer Enters Into Collaboration With Washington University | 25 | 2 |
| Merger | 27 | 1 |
| Northwest Hospital Merges With UW Medicine | 27 | 1 |
| Licensing Agreements | 28 | 1 |
| Denali Therapeutics Enters into Licensing Agreement with Washington University School of Medicine | 28 | 1 |
| Optikira Enters into Licensing Agreement with University of California, San Francisco and University of Washington | 29 | 1 |
| Avalanche Biotech Enters into Licensing Agreement with University of Washington | 30 | 1 |
| Sage Therapeutics Enters Into Licensing Agreement With Washington University To Develop Gaba Receptor Small Molecules | 31 | 1 |
| GenetikSignal Enters Into Licensing Agreement With University Of Washington | 32 | 1 |
| ChromaDex Enters Into Licensing Agreement With Washington University For Nicotinamide Riboside | 33 | 1 |
| Nexgenia Enters into Licensing Agreement with University of Washington | 34 | 1 |
| Resolve Therapeutics Enters Into Licensing Agreement With University of Washington | 35 | 1 |
| AttoDx Enters Into Licensing Agreement With University Of Washington And Seattle BioMed | 36 | 1 |
| Genocea Enters Into Licensing Agreement With University of Washington And Fred Hutchinson Cancer Research Center | 37 | 1 |
| University of Washington - Key Competitors | 38 | 1 |
| Key Employees | 39 | 1 |
| Locations And Subsidiaries | 40 | 2 |
| Head Office | 40 | 1 |
| Other Locations &Subsidiaries | 40 | 2 |
| Appendix | 42 | 1 |
| Methodology | 42 | 1 |
| About GlobalData | 42 | 1 |
| Contact Us | 42 | 1 |
| Disclaimer | 42 | 1 |